184 results on '"Yuza, Yuki"'
Search Results
2. Information needs of children with leukemia and their parents’ perspectives of their information needs: a qualitative study
3. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
4. False-Positive Asymmetrical Tongue Muscle 18F-FDG Uptake in Hypoglossal Nerve Paralysis Following Lymph Node Dissection in a Pediatric Patient with Malignant Rhabdoid Tumor of the Neck
5. Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective
6. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects
7. Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma.
8. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients
9. Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: A protocol for a randomized phase 2 trial
10. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults
11. Prevalence of pathogenic variants in cancer‐predisposing genes in second cancer after childhood solid cancers
12. Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain.
13. Ewing’s Sarcoma with Extension into Superior Vena Cava and Right Atrium
14. A Fatal Case of Neuroblastoma Complicated by Posterior Reversible Encephalopathy with Rapidly Evolving Transplantation-Associated Thrombotic Microangiopathy
15. Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy
16. Safety and Efficacy of Arsenic Trioxide in the Treatment of Newly Diagnosed Pediatric Acute Promyelocytic Leukemia: Results from the JPLSG AML-P13 Study
17. Evaluation of High-Dose Cytarabine Induction Therapy and Flow Cytometric Measurable Residual Disease Monitoring for Children with De Novo Acute Myeloid Leukemia: A Report from the JPLSG-AML-12 Trial
18. Primary alveolar rhabdomyosarcoma of the diaphragm requiring proximal gastrectomy
19. PEDT-9 A study of NovoTTF-100A to expand the regulatory indication for childhood glioblastoma through a pediatric clinical trial based on the Advanced Medical Care system
20. A Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study
21. Epidermal Growth Factor Receptor Variant III Mutations in Lung Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
22. Predictive factors of acute respiratory events during initial induction chemotherapy in patients with advanced neuroblastoma
23. PS3-5 Phase III study of palonosetron for preventing chemotherapy-induced nausea and vomiting in pediatric patients
24. Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan
25. Phase III study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients
26. Tumor-Treating Fields Therapy for Pediatric Brain Tumors
27. Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide and Antithymocyte Globulin from HLA-Mismatched Related Donors for Nonmalignant Diseases
28. Predictive factors of acute respiratory events during initial induction chemotherapy in patients with advanced neuroblastoma.
29. The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22
30. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
31. Etoposide, Cytarabine and Mitoxantrone- or Fludarabine, Cytarabine and Granulocyte Colony-Stimulating Factor-Based Intensive Reinduction Chemotherapy Is Recommended for Children with Relapsed Acute Myeloid Leukemia: The Results from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R Study
32. A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes
33. NUDT15 Variants Confer High Incidence of Secondary Malignancies of ALL in Children
34. Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)
35. aa
36. Evaluation of High-Dose Cytarabine Induction Therapy and Flow Cytometric Measurable Residual Disease Monitoring for Children with De NovoAcute Myeloid Leukemia: A Report from the JPLSG-AML-12 Trial
37. Copy Number Amplification of the PIK3CA Gene Is Associated with Poor Prognosis in Non-lymph node metastatic Head and Neck Squamous Cell Carcinoma
38. Rationale and Design of a Prospective, Multicentre, Stop Tyrosine Kinase Inhibitor Trial of Paediatric Patients with Chronic Myeloid Leukaemia with Sustained Complete Molecular Response (STKI-14)
39. Initial Symptoms of Langerhans Cell Histiocytosis: A Case Series
40. Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module
41. NUDT15variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
42. Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese
43. A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group
44. ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
45. Antimicrobial Stewardship Program at Hematology-Oncology and Hematopoietic Stem Cell Transplant Wards at a Children's Hospital in Japan
46. Genetic Susceptibility Loci for Childhood Acute Lymphoblastic Leukemia Among Japanese
47. Interim Analysis of a Multicenter, Prospective Study for Pediatric Chronic Myeloid Leukemia in Chronic Phase: The JPLSG CML-08 Study
48. High Event-Free Survival Rate with Minimum-Dose-Anthracycline Treatment in Childhood Acute Promyelocytic Leukemia: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)
49. Recombinant Thrombomodulin Safely Controls Disseminated Intravascular Coagulopathy in Acute Promyelocytic Leukemia – Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-P05 Study
50. Abstract A9: Uridine diphospho glucuronosyl-transferase 2B17 genotype and a risk of acute lymphoblastic leukemia and lymphoblastic lymphoma among Japanese children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.